Complement activation by human IgG antibodies to galactose‐α‐1,3‐galactose
- 24 June 2020
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 161 (1) , 66-79
Abstract
Summary: Some human antibodies may paradoxically inhibit complement activation on bacteria and enhance pathogen survival in humans. This property was also claimed for IgG antibodies reacting with terminal galactose‐α‐1,3‐galactose (Galα3Gal; IgG anti‐αGal), a naturally occurring and abundant antibody in human plasma that targets numerous different pathogens. To reinvestigate these effects, we used IgG anti‐αGal affinity isolated from a pool of normal human IgG and human hypogammaglobulinaemia serum as a complement source. Flow cytometry was performed to examine antibody binding and complement deposition on pig erythrocytes, Escherichia coli O86 and Streptococcus pneumoniae serotype 9V. Specific nanobodies were used to block the effect of single complement factors and to delineate the complement pathways involved. IgG anti‐αGal was capable of activating the classical complement pathway on all the tested target cells. The degree of activation was exponentially related to the density of bound antibody on E. coli O86 and pig erythrocytes, but more linearly on S. pneumoniae 9V. The alternative pathway of complement amplified complement deposition. Deposited C3 fragments covered the activating IgG anti‐αGal, obstructing its detection and highlighting this as a likely general caveat in studies of antibody density and complement deposition. The inherent capacity for complement activation by the purified carbohydrate reactive IgG anti‐αGal was similar to that of normal human IgG. We propose that the previously reported complement inhibition by IgG anti‐αGal relates to suboptimal assay configurations, in contrast to the complement activating property of the antibodies demonstrated in this paper.Keywords
Funding Information
- Aarhus Universitet
This publication has 46 references indexed in Scilit:
- Structural Characterization of Streptococcus pneumoniae Serotype 9A Capsule Polysaccharide Reveals Role of Glycosyl 6-O-Acetyltransferase wcjE in Serotype 9V Capsule Biosynthesis and ImmunogenicityJournal of Biological Chemistry, 2012
- Complement deficiency states and associated infectionsMolecular Immunology, 2011
- Novel Blocking Human IgG Directed against the Pentapeptide Repeat Motifs of Neisseria meningitidis Lip/H.8 and Laz LipoproteinsThe Journal of Immunology, 2011
- Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serumBiotechnology Journal, 2009
- Naturally occurring α-galactosyl antibodies in human sera display polyreactivityImmunology Letters, 1999
- Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Journal of Clinical Investigation, 1995
- Differences in outer membrane characteristics between gallstone-associated bacteria and normal bacterial floraThe Lancet, 1994
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.Journal of Experimental Medicine, 1987
- Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide AntigensNew England Journal of Medicine, 1980
- Interaction of human Clq with insoluble immunoglobulin aggregatesImmunochemistry, 1978